You searched for "lid"
Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines
There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.Zoom
One of the side-effects of the coronavirus pandemic is that suddenly everything is now done on Zoom. In case anyone is fortunate enough to have no idea what this is, Zoom is an app that allows virtual meetings to take...The importance of ‘hands-on’ learning
Providing ongoing professional education and development for the allied professions out of the clinic or hospital setting is often quite challenging. The reorganisation of rotas, heavy clinic lists and financial constraints all add up to making the opportunity to learn...Charles Bonnet Syndrome emerges from the shadows
There has been a ground-breaking response to the online Charles Bonnet Syndrome Patient Information event on 16 November.
CAT-QoL questionnaire
The purpose of this study was to use Rasch analysis to inform the refinement of the CAT-QoL amblyopia treatment questionnaire. Of the 342 subjects that were recruited across nine centres, 315 had sufficient clinical data for analysis with RUMM software....
Use of group consultations in the management of idiopathic intracranial hypertension
The incidence of idiopathic intracranial hypertension (IIH) has risen by >100% between 2002 and 2016 in the UK, in association with rising obesity rates. This increasing incidence has inevitably led to increased pressures on service capacity. Evidence for other conditions...WATCH EPISODE 6: Beyond 2020 with the Andean Medical Mission
Welcome to the sixth episode of Beyond 2020, the series that looks at strategies to eliminate avoidable blindness in countries with developing eyecare services and shares ideas and solutions to common difficulties in working abroad.
Overview of traumatic optic neuropathy
The authors present the clinical features and role of various treatment modalities on the final vision outcome in traumatic optic neuropathy (TON). They retrospectively reviewed the records of patients with a diagnosis of TON over a four year period in...
ANGPTL-4 inhibition reduces inflammation in diabetic retinopathy
Diabetic retinopathy (DR) is the most common cause of blindness in working-age humans, and numbers are rising due to increased cases of type 2 diabetes (T2D). T2D is associated with increased obesity and dyslipidaemia, which is a major risk factor...
Statins inhibit TGFβ2 mediated fibrotic response in astrocytes
Glaucoma is a common condition where increased ocular pressure can lead to death of retinal ganglion cells due to impaired drainage of fluid from the eye. One mechanism involved in glaucoma is remodelling of the extracellular matrix at the lamina...
MicroRNAs in cataract
In an ageing population cataract formation is one of the leading causes of blindness. Cataracts are caused by a failure to clear accumulating aggregated proteins in the lens. MicroRNAs are small non-coding transcripts which bind to specific mRNAs acting at...
